NDC 62541-406

PANCREAZE

Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease

PANCREAZE is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Vivus, Inc.. The primary component is Pancrelipase Lipase; Pancrelipase Amylase; Pancrelipase Protease.

• Product ID: 62541-406_c2c57671-5682-04ff-e053-2a95a90a8cc7
• NDC: 62541-406
• Product Type: Human Prescription Drug
• Proprietary Name: PANCREAZE
• Generic Name: Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease
• Dosage Form: Capsule, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-31
• Marketing Category: BLA /
• Application Number: BLA022523
• Labeler Name: VIVUS, Inc.
• Substance Name: PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE
• Active Ingredient Strength: 37000 [USP'U]/1; [USP'U]/1; [USP'U]/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 62541-406-10

2 BOTTLE, GLASS in 1 CARTON (62541-406-10) > 50 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS (62541-406-50)

• Marketing Start Date: 2021-07-31
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "PANCREAZE" or generic name "Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease"

NDC	Brand Name	Generic Name
50458-341	PANCREAZE	PANCRELIPASE
50458-342	PANCREAZE	PANCRELIPASE
50458-343	PANCREAZE	PANCRELIPASE
50458-346	PANCREAZE	PANCRELIPASE
50458-347	PANCREAZE	PANCRELIPASE
62541-401	PANCREAZE	PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
62541-402	PANCREAZE	PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
62541-403	PANCREAZE	PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
62541-404	PANCREAZE	PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
62541-405	PANCREAZE	PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE